This is in line with previous observations of the α3 protein levels in MDA-MB-231 and SKBR3 cells [20] and suggests that downregulation of α3β1 integrin is associated with HER2-driven mammary tumorigenesis and tumor progression. The gene discussed is ERBB2; the disease is neoplasm.